Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

Immunology and Infection

Isolation of Mouse Lung Dendritic Cells

doi: 10.3791/3563 Published: November 22, 2011

Summary

A highly purified preparation of mouse lung dendritic cells is described. Specific emphasis is given to the isolation of conventional dendritic cell subset.

Abstract

Lung dendritic cells (DC) play a fundamental role in sensing invading pathogens 1,2 as well as in the control of tolerogenic responses 3 in the respiratory tract. At least three main subsets of lung dendritic cells have been described in mice: conventional DC (cDC) 4, plasmacytoid DC (pDC) 5 and the IFN-producing killer DC (IKDC) 6,7. The cDC subset is the most prominent DC subset in the lung 8.

The common marker known to identify DC subsets is CD11c, a type I transmembrane integrin (β2) that is also expressed on monocytes, macrophages, neutrophils and some B cells 9. In some tissues, using CD11c as a marker to identify mouse DC is valid, as in spleen, where most CD11c+ cells represent the cDC subset which expresses high levels of the major histocompatibility complex class II (MHC-II). However, the lung is a more heterogeneous tissue where beside DC subsets, there is a high percentage of a distinct cell population that expresses high levels of CD11c bout low levels of MHC-II. Based on its characterization and mostly on its expression of F4/80, an splenic macrophage marker, the CD11chiMHC-IIlo lung cell population has been identified as pulmonary macrophages 10 and more recently, as a potential DC precursor 11.

In contrast to mouse pDC, the study of the specific role of cDC in the pulmonary immune response has been limited due to the lack of a specific marker that could help in the isolation of these cells. Therefore, in this work, we describe a procedure to isolate highly purified mouse lung cDC. The isolation of pulmonary DC subsets represents a very useful tool to gain insights into the function of these cells in response to respiratory pathogens as well as environmental factors that can trigger the host immune response in the lung.

Protocol

1. Lung perfusion and single cell suspension

  1. Euthanize the mouse with an intraperitoneal injection of ketamine/xylazine anesthetic mixture (in mg/mouse ketamine 1.8, xylazine 0.19) and exsanguination via the femoral vein
  2. Expose the thoracic cavity by cutting and gently pulling back the outer skin of the peritoneum. Proceed to open the diaphragm by cutting the rib cage to expose both the heart and lungs.
  3. Perfuse gently the lungs using a 5 ml syringe filled with EDTA-HBSS (1mM EDTA in calcium/Magnesium-free HBSS). Connect a 25 G needle and insert needle into the right ventricle. To prevent leakage during injection, secure the myocardiac tissue around the needle by using forceps. Gently inject solution while maintaining a constant pressure. Accurate perfusion will result in lung inflation and a color change to pink/white.
  4. Remove draining lymph nodes to discard any potential contamination from this tissue.
  5. Collect lung tissue, transfer to a petri dish on ice, and chop it to small pieces using a razor blade.
  6. Transfer grounded tissue into a gentleMACS C tube containing 5 ml/lung of collagenase digestion solution (collagenase type 1A 0.5 mg/ml plus type IV bovine pancreatic DNase 20 μg/ml in HBSS containing 5% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin).
  7. Use the gentleMACS dissociator to obtain a single cell suspension. Choose program: m_lung_01. Incubate sample at 37 °C for 30 minutes. Shake tube every 5 minutes to resuspend tissue fragments. Proceed with program m_lung_02.
  8. Transfer sample to a 15 ml conical tube and centrifuge for 10 minutes at 335 x g at 4 °C. After this step, keep all reagents and centrifugations at 4 °C to prevent reduction in cell viability.
  9. Discard supernatant and lyse remaining red blood cells by adding 2 ml of ACK lysing buffer for 1 minute at room temperature. Wash cells with 13 ml of cold PBS/0.5% BSA and centrifuge for 10 minutes at 335 x g at 4°C.
  10. Discard supernatant, resuspend total cells in 5 ml of cold PBS/0.5%BSA and pass thorough a 100 μm nylon mesh.
  11. Determine the total cell number by using trypan blue exclusion dye.

2. Magnetic isolation and CD11c+ cells enrichment

  1. Centrifuge single cell suspension for 10 minutes at 200 x g at 4 °C and discard supernatant.
  2. Resuspend cell pellet in 400 μl of separation buffer (PBS, 0.5% BSA, and 2 mM EDTA) per 108 total cells. Block Fc-mediated unspecific antibody binding by using anti-CD16/CD32 antibody (0.5μg/ 106 cells) for 30 minutes at 4 °C.
  3. Wash cells with 10 ml of cold separation buffer and centrifuge for 10 minutes at 200 x g at 4 °C. Resuspend cells in 400 μl of separation buffer.
  4. Add 100 μl of CD11c MicroBeads per 108 total cells. Mix well and incubate for 15 minutes in the refrigerator (2-8 °C).
  5. Wash cells with 10 ml of cold separation buffer and centrifuge for 10 minutes at 200 x g at 4 °C and discard supernatant.
  6. Resuspend the cell pellet in 3 ml of cold separation buffer.
  7. Perform magnetic separation using the autoMACS ProTM Separator by selecting the program posseld. Collect the positive fraction (0.5 ml).

3. Conventional dendritic cell (cDC) isolation

  1. Incubate enriched CD11c positive cell suspension with anti-CD11c PE-Cy7 and anti-I-A/I-E (MHC-II)-FITC antibodies for 30 minutes at 4 °C. Optimized concentration of antibodies is 0.5 μg/ 106 of cells.
  2. Wash cells with cold PBS/0.5% BSA and centrifuge for 10 minutes at 335 x g at 4 °C. Resuspend cells in 0.5 ml of PBS/0.5% BSA and pass them through a 40 μm nylon mesh.
  3. Proceed to sort the cells by using the FACS Aria cell sorter in the purity mode. Add 100 μl of PBS/0.5% BSA to the collection tubes in order to prevent damage of purified cells. Keep your cells at a refrigerated temperature throughout the cell sorting process.

4. Alternate protocol for obtaining a single cell suspension and CD11c+ cells enrichment

  1. In replacement of the gentleMACS dissociator, grounded lung tissue from step 1.5 can be transferred to a 15 ml conical tube containing 5 ml of collagenase solution per lung and incubate for 1 hour at 37 °C. Vortex cells every 15 minutes in order to resuspend tissue fragments. Disrupt the tissue by passing the sample 6-8 times in and out through a 3 ml syringe connected to a 20 G needle. Avoid making bubbles during the process, otherwise the cell viability will be compromised. Once single cell suspension is obtained, continue to step 1.8.
  2. In replacement of the AutoMACSProTM separator, magnetic isolation for the enrichment of the CD11c cells, can also be performed by passing the cell suspension manually through two MACS columns. The selection of the appropriate columns will vary depending of the sample size.

5. Representative Results:

Lung cDC are identified as CD11chi/MHC-IIhi cell population. As shown in Fig. 1, cDC represent a smaller percentage of 1.4% when compared to some other tissues such as spleen (4.8%). However, in contrast to spleen, lung CD11c positive cells express different amounts of MHC-II, including a cell population different than that of cDC. After the single-cell preparation, the cell yield of total lung cells was about 3.0 to 3.8 x 107 cells/lung with a viability of 60-70 % from which a little over 1% represented cDC subset. This percentage was increased after the CD11c magnetic isolation where the total lung cDC was incremented about 10 times (>16%) from the original preparation (Fig. 2A). However, CD11c cells expressing low amounts of MHC-II (CD11chi/MHC-IIlo, macrophages) represented a high contaminating cell population (>70%) which was mixed with the lung cDC subset. As shown in Fig. 2B, those cells were eliminated after the cell sorting step when the cDC purity reached >96%. The usual yield of cDC after the whole procedure was 5 x 104 cells/lung. Microphotographs show morphological characteristics of cDC as rounded cells with the typical dendrites (upper panel). On the other hand, CD11chi/MHC-IIlo represented a morphologically different subset that shows cellular protuberances which are typical of macrophages (MΦ, lower panel) 12.

Figure 1
Figure 1. Differential DC frequency in mouse lung and spleen. Lung and spleen tissue from C57BL/6 mice were collected and treated with collagenase. Following collagenase digestion, cells were stained with anti-mouse CD11c-PE-Cy7 and anti-mouse I-A/I-E-FITC. Representative flow cytometry plots show percentages of cDC (CD11chi/MHC-IIhi) in lung and spleen.

Figure 2
Figure 2. Isolation of cDC from mouse lung. Mouse lung single cell suspension was labeled with anti-CD11c microbeads and passed through an automatic cell separator. A) A representative plot shows the percentages of cDC (CD11chi/MHC-IIhi) and Macrophages (MΦ, CD11chi/MHC-IIlo) populations after CD11c enrichment. Further staining of the enriched fraction followed using anti-mouse CD11c-PE-Cy7 and anti-mouse I-A/I-E-FITC. Double positive cells were sorted and analyzed by flow cytometry. To identify their morphology, cells were cytospun and stained with a modified Wright-Giemsa staining. B) Representative plots show percentages of cDC and MΦ after cell sorting. Microphotographs show a representative image of lung cDC and lung MΦ. Scale bar = 20 μm.

Subscription Required. Please recommend JoVE to your librarian.

Discussion

Isolation of pulmonary mouse DC is an important technique for the study of a wide range of respiratory stimuli. The process of obtaining these cells includes critical steps that prevent loss of cells as well as cell viability and purity. Perfusing the lung before collection will help to eliminate any peripheral cells as well as reduce contaminant erythrocytes. The use of the automated dissociation can be advanteogus when a large number of lungs are handled, otherwise you can opt for the alternative protocol, keeping in mind that the dispersion of the tissue after collagenase digestion should be done gently when done manually. The incubation period of the lung tissue while in collagenase solution should not be extended beyond the indicated incubation time. After this step, the remaining process must be done using ice-cold buffers and refrigerated centrifuges to reduce cell death. The lysis of contaminating erythrocytes is a step that should not be repeated more than twice during the whole process. Passing the cell suspension through a nylon mesh, at the indicated steps, is critical to prevent clogging of the cell sorter as well as to reduce cell aggregates which will compromise the cell purity. If further culture in vitro of the isolated cells is involved, all steps must be performed under a biosafety cabinet to prevent any contamination. It is not expected that the cell sorting step will compromise the sterility of the sample.

Dendritic cells are crucial for studies of the innate and adaptive immune interactions. The procedure described has the potential to be applied for the isolation of other DC subsets if appropriate antibodies are used during the magnetic isolation and the cell sorting 8. In addition, pulmonary macrophages (CD11chi/MHC-IIlo) can also be purified from the same cell preparation. Despite the limited number of pulmonary DC that can be isolated per animal by using this procedure, this technique provides the most accurate system to study lung DC. However, prior to DC isolation, mice could be treated with Fms-Like tyrosine kinase 3 (Flt3-) Ligand, an agent that increases DC numbers 13 . Although spleen DC may be easier and faster to isolate, the differences in the maturation state of the DC in lung and spleen must be taken into consideration. In contrast to spleen DC, lung DC express an immature phenotype that is switched to a mature one after e.g. a viral infection8,14.

In summary, the isolation of the specific subsets of lung DC through the described protocol, provides a unique tool that can help to determine the specific role and/or contribution of pulmonary DC in the host immune responses and can be applied to any experimental mouse model that involves the study of the respiratory tract.

Subscription Required. Please recommend JoVE to your librarian.

Disclosures

The authors have nothing to disclose.

Acknowledgments

The authors would like to thank to Marilyn Dietrich at the LSU Flow Cytometry Core Facility for her help with the cell sorting and Peter Mottram for his assistance with the microphotographs. This work was funded by the Flight Attendant Medical Research Institute, the LSU-Competitive Research Program Award, and the NIH/NIAID Grants P20 RR020159 and R03AI081171.

Materials

Name Company Catalog Number Comments
ACK lysing buffer Invitrogen D6-0005DG
Anti-mouse CD11c (HL3) BD Biosciences 5580979 PE-Cy7 conjugated
Anti-mouse I-A/I-E (269) BD Biosciences 553623 FITC conjugated
Collangenase Type 1A Sigma-Aldrich 9891-500MG
Cell strainers BD Biosciences 352340, 352360
CD11c (N418) Microbeads Miltenyi Biotec 130-052-001
DNase I Sigma-Aldrich D5025-150KU
Hank’s Balanced Salt solution Invitrogen 14170
Hepes buffer solution Invitrogen 15630
Petri dishes 60 mm BD Biosciences 351016
GentleMACS™ C tubes Miltenyi Biotec 130-093-237
Gentle MACS dissociator Miltenyi Biotec 130-093-235
AutoMACS-Pro™ Miltenyi Biotec 130-092-545
FASCS Aria BD Biosciences

DOWNLOAD MATERIALS LIST

References

  1. Pulendran, B., Palucka, K., Banchereau, J. Sensing pathogens and tuning immune responses. Science. 293, 253-256 (2001).
  2. Banchereau, J. Immunobiology of dendritic cells. Annual Review of Immunology. 18, 767-811 (2000).
  3. Manicassamy, S., Pulendran, B. Dendritic cell control of tolerogenic responses. Immunol. Rev. 241, 206-227 (2011).
  4. Steinman, R. M., Cohn, Z. A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162 (1973).
  5. Asselin-Paturel, C. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150 (2001).
  6. Chan, C. W. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12, 207-213 (2006).
  7. Taieb, J. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12, 214-219 (2006).
  8. Guerrero-Plata, A., Kolli, D., Hong, C., Casola, A., Garofalo, R. P. Subversion of pulmonary dendritic cell function by paramyxovirus infections. Journal of Immunology. 182, 3072-3083 (2009).
  9. Larson, R. S., Springer, T. A. Structure and function of leukocyte integrins. Immunol. Rev. 114, 181-217 (1990).
  10. Sung, S. S. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176, 2161-2172 (2006).
  11. Wang, H. Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process. J. Immunol. 177, 2536-2542 (2006).
  12. Bhatia, S. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS One. 6, e15943-e15943 (2011).
  13. Shao, Z., Makinde, T. O., McGee, H. S., Wang, X., Agrawal, D. K. Fms-like tyrosine kinase 3 ligand regulates migratory pattern and antigen uptake of lung dendritic cell subsets in a murine model of allergic airway inflammation. J. Immunol. 183, 7531-75381 (2009).
  14. Hao, X., Kim, T. S., Braciale, T. J. Differential response of respiratory dendritic cell subsets to influenza virus infection. J. Virol. 82, 4908-4919 (2008).
Isolation of Mouse Lung Dendritic Cells
Play Video
PDF DOI

Cite this Article

Lancelin, W., Guerrero-Plata, A. Isolation of Mouse Lung Dendritic Cells. J. Vis. Exp. (57), e3563, doi:10.3791/3563 (2011).More

Lancelin, W., Guerrero-Plata, A. Isolation of Mouse Lung Dendritic Cells. J. Vis. Exp. (57), e3563, doi:10.3791/3563 (2011).

Less
Copy Citation Download Citation Reprints and Permissions
View Video

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter